Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Determine the effect of Vancomycin Powder added to the surgical wound at closure on surgical infection rates.
Study will be blinded and randomized 1:1 to either Vancomycin Powder at closure or no vancomycin powder at closure.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Vancomycin | Experimental | Patient will receive Vancomycin powder to the incision just before skin closure |
|
| no vancomycin | No Intervention | Patient will be randomized to either vancomycin powder or no vancomycin powder. This arm the patient will not have the powder placed in the incision before skin closure. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Vancomycin | Drug | Patient will be randomized to either vancomycin or no vancomycin. This treatment will take place prior to the closure of the incision from back surgery. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Surgical wound infection rate, both deep and superficial infections | 12 weeks post surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Post-operative rate of MRSA infections. | 12 weeks post surgery |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jason Squires, DO | Corewell Health West | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Spectrum Health Hospitals | Recruiting | Grand Rapids | Michigan | 49503 | United States |
| Type | Date | Date Unknown |
|---|---|---|
| Release | Jan 25, 2023 | |
| Reset | Feb 21, 2023 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Jan 25, 2023 | Feb 21, 2023 |
| ID | Term |
|---|---|
| D017116 | Low Back Pain |
| D007239 | Infections |
| D013530 | Surgical Wound Infection |
| ID | Term |
|---|---|
| D001416 | Back Pain |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D014640 | Vancomycin |
| ID | Term |
|---|---|
| D006020 | Glycopeptides |
| D006001 | Glycoconjugates |
| D002241 | Carbohydrates |
| D010455 | Peptides |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D014946 | Wound Infection |
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D000602 |
| Amino Acids, Peptides, and Proteins |